Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | Home - Lytix |
Description | Press Toggle navigation About About us Management Team Board of Directors Advisory Board Partnering Research & Development Immuno-oncology Technology Collaborat |
Keywords | N/A |
WebSite | lytixbiopharma.com |
Host IP | 217.160.183.146 |
Location | Germany |
Site | Rank |
US$2,516,243
Last updated: 2023-05-04 15:21:09
lytixbiopharma.com has Semrush global rank of 4,206,392. lytixbiopharma.com has an estimated worth of US$ 2,516,243, based on its estimated Ads revenue. lytixbiopharma.com receives approximately 290,336 unique visitors each day. Its web server is located in Germany, with IP address 217.160.183.146. According to SiteAdvisor, lytixbiopharma.com is safe to visit. |
Purchase/Sale Value | US$2,516,243 |
Daily Ads Revenue | US$2,323 |
Monthly Ads Revenue | US$69,681 |
Yearly Ads Revenue | US$836,167 |
Daily Unique Visitors | 19,356 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
lytixbiopharma.com. | A | 3599 | IP: 217.160.183.146 |
lytixbiopharma.com. | NS | 86400 | NS Record: ns2.hyp.net. |
lytixbiopharma.com. | NS | 86400 | NS Record: ns1.hyp.net. |
lytixbiopharma.com. | NS | 86400 | NS Record: ns3.hyp.net. |
lytixbiopharma.com. | MX | 3600 | MX Record: 10 mail.intility.com. |
lytixbiopharma.com. | MX | 3600 | MX Record: 10 mail2.intility.com. |
lytixbiopharma.com. | TXT | 3600 | TXT Record: MS=ms98364005 |
Toggle navigation About About us Management Team Board of Directors Advisory Board Partnering Research & Development Immuno-oncology Technology Collaborations Publications Posters Investors Overview The share Shareholder information Largest shareholders Financial calendar Reports & Presentations Financial Reports Presentations Information Document Events IR Contact News Press releases & other news Subscribe Contact --> post@lytixbiopharma.com Press Releases Other News Apr 12 2023 First patient dosed in Part 2 of Verrica Pharmaceuticals’ Phase II study evaluating LTX-315 Read more... Mar 22 2023 Lytix Biopharma appoints Karsten Bruins Slot as Director Clinical Development Read more... Mar 14 2023 Lytix is hiring - looking for a CMC Manager Read more... Mar 09 2023 Our CEO, Øystein Rekdal, has been interview by Health Talk Read more... Mar 07 2023 Verrica Pharmaceuticals with positive update on how they are advancing our lead compound LTX-315 through their Phase II trial Read more... |
HTTP/1.1 301 Moved Permanently Server: nginx Date: Tue, 26 Oct 2021 16:33:52 GMT Content-Type: text/html Content-Length: 162 Connection: keep-alive Location: https://lytixbiopharma.com/ HTTP/2 200 server: nginx date: Tue, 26 Oct 2021 16:33:53 GMT content-type: text/html; charset=utf-8 x-powered-by: PHP/7.4.24 expires: Thu, 19 Nov 1981 08:52:00 GMT cache-control: no-store, no-cache, must-revalidate pragma: no-cache set-cookie: CMSSESSIDbe10ebaffeb5=8tuk47apval6v5gt3k2imu6aqk; path=/ x-powered-by: PleskLin |
Domain Name: LYTIXBIOPHARMA.COM Registry Domain ID: 107747238_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.domainnameshop.com Registrar URL: http://www.domainnameshop.com Updated Date: 2020-12-05T22:54:54Z Creation Date: 2003-12-05T10:14:27Z Registry Expiry Date: 2021-12-05T10:14:27Z Registrar: Domeneshop AS dba domainnameshop.com Registrar IANA ID: 1001 Registrar Abuse Contact Email: abuse@domainnameshop.com Registrar Abuse Contact Phone: +47.22943333 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS1.HYP.NET Name Server: NS2.HYP.NET Name Server: NS3.HYP.NET DNSSEC: signedDelegation DNSSEC DS Data: 32564 13 4 5321F921877B4C7D4AC719C5331EAEC0C335E2785FDBCE415EF5726086E200BDE135D248F3B9DC8C71597DC1CB7D2A8A DNSSEC DS Data: 32564 13 2 1AF418C2B08610D5FDCD1D56057468D6CC0CD4C0A5AFD11B692E6616AC2E2355 >>> Last update of whois database: 2021-09-14T16:22:36Z <<< |